{"id":224448,"date":"2026-03-12T14:19:00","date_gmt":"2026-03-12T18:19:00","guid":{"rendered":"https:\/\/news-you-need.com\/index.php\/2026\/03\/12\/rethinking-drug-design-the-growing-role-of-generative-models-in-early-stage-drug-rd\/"},"modified":"2026-03-17T02:10:12","modified_gmt":"2026-03-17T06:10:12","slug":"rethinking-drug-design-the-growing-role-of-generative-models-in-early-stage-drug-rd","status":"publish","type":"post","link":"https:\/\/news-you-need.com\/index.php\/2026\/03\/12\/rethinking-drug-design-the-growing-role-of-generative-models-in-early-stage-drug-rd\/","title":{"rendered":"Rethinking drug design: The growing role of generative models in early-stage drug R&#038;D"},"content":{"rendered":"<p><a href=\"https:\/\/venturebeat.com\/business\/rethinking-drug-design-the-growing-role-of-generative-models-in-early-stage\">Rethinking drug design: The growing role of generative models in early-stage drug R&#038;D<\/a><\/p>\n<p><a href=\"https:\/\/venturebeat.com\/business\/rethinking-drug-design-the-growing-role-of-generative-models-in-early-stage\">https:\/\/venturebeat.com\/business\/rethinking-drug-design-the-growing-role-of-generative-models-in-early-stage<\/a><\/p>\n<p>Publish Date: <a href=\"publish_date]\">2026-03-12 14:19:00<\/a><\/p>\n<p>Source Domain: <a href=\"venturebeat.com\">venturebeat.com<\/a><\/p>\n<p>Despite decades of progress in pharmaceutical R&#038;D, the earliest phase of drug discovery\u2014where molecules are conceived and designed\u2014remains costly, inefficient, and burdened by high failure rates. Most experimental compounds never reach clinical development, and those that do often take over a decade and billions of dollars to bring to market.<\/p>\n<p>These bottlenecks are rooted in the limitations of traditional methodologies, which rely heavily on screening vast libraries of known compounds in hopes of finding a match. At the same time, alternative approaches are gaining attention. Generative AI can be used to propose new molecular candidates during early discovery, shifting from search-and-filter to true design and invention. Variational AI, through its proprietary platform Enki\u2122, is helping lead this transition.<\/p>\n<h2>Addressing bottlenecks in early-stage research<\/h2>\n<p>Historically, drug discovery has been dominated by high-throughput screening, where researchers sift through extensive compound libraries experimentally or, more recently, virtually, using discriminative algorithms to prioritize hits. This process, while increasingly digitized, is still governed by what already exists. As a result, it often takes years to move from hit identification to lead optimization and pre-clinical candidates, with a steep attrition curve along the way.<\/p>\n<p>Furthermore, trial-and-error experimentation and siloed data can contribute to longer timelines and higher development costs. With average R&#038;D expenditures exceeding $2.6 billion per approved drug, and timelines stretching over a decade, the need for innovation at the design stage is clear.<\/p>\n<p>Generative AI offers a different approach to this phase\u2014not by speeding up what exists, but by expanding the range of explored possibilities.<\/p>\n<h2>The strategic edge of generative over discriminative models<\/h2>\n<p>While many pharmaceutical companies have embraced AI, the majority rely on discriminative models that classify, rank, or predict properties of&#8230;<\/p>\n<p><a href=\"https:\/\/venturebeat.com\/business\/rethinking-drug-design-the-growing-role-of-generative-models-in-early-stage\">Source<\/a><\/p>\n","protected":false},"excerpt":{"rendered":"<p>Rethinking drug design: The growing role of generative models in early-stage drug R&#038;D https:\/\/venturebeat.com\/business\/rethinking-drug-design-the-growing-role-of-generative-models-in-early-stage Publish&#8230;<\/p>\n","protected":false},"author":1,"featured_media":224449,"comment_status":"closed","ping_status":"","sticky":false,"template":"","format":"standard","meta":{"fifu_image_url":"https:\/\/images.ctfassets.net\/jdtwqhzvc2n1\/266V5b9iulvcRPXQWfGMG1\/c5c075b3fd5aebb672f7b1a72f137f14\/unnamed-1__3_.jpg?w=800&q=75","fifu_image_alt":"","footnotes":""},"categories":[14],"tags":[19],"class_list":["post-224448","post","type-post","status-publish","format-standard","has-post-thumbnail","hentry","category-artificial-intelligence","tag-generative-ai"],"_links":{"self":[{"href":"https:\/\/news-you-need.com\/index.php\/wp-json\/wp\/v2\/posts\/224448"}],"collection":[{"href":"https:\/\/news-you-need.com\/index.php\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/news-you-need.com\/index.php\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/news-you-need.com\/index.php\/wp-json\/wp\/v2\/users\/1"}],"replies":[{"embeddable":true,"href":"https:\/\/news-you-need.com\/index.php\/wp-json\/wp\/v2\/comments?post=224448"}],"version-history":[{"count":1,"href":"https:\/\/news-you-need.com\/index.php\/wp-json\/wp\/v2\/posts\/224448\/revisions"}],"predecessor-version":[{"id":224450,"href":"https:\/\/news-you-need.com\/index.php\/wp-json\/wp\/v2\/posts\/224448\/revisions\/224450"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/news-you-need.com\/index.php\/wp-json\/wp\/v2\/media\/224449"}],"wp:attachment":[{"href":"https:\/\/news-you-need.com\/index.php\/wp-json\/wp\/v2\/media?parent=224448"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/news-you-need.com\/index.php\/wp-json\/wp\/v2\/categories?post=224448"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/news-you-need.com\/index.php\/wp-json\/wp\/v2\/tags?post=224448"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}